Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease

Neutralization of Omicron subvariants by different bivalent vaccines has not been well evaluated. This study characterizes neutralization against Omicron subvariants in 98 individuals on dialysis or with a kidney transplant receiving the BNT162b2 (BA.4/BA.5) or mRNA-1273 (BA.1) bivalent COVID-19 vac...

Descripción completa

Detalles Bibliográficos
Autores principales: Yau, Kevin, Kurtesi, Alexandra, Qi, Freda, Delgado-Brand, Melanie, Tursun, Tulunay R., Hu, Queenie, Dhruve, Miten, Kandel, Christopher, Enilama, Omosomi, Levin, Adeera, Jiang, Yidi, Hardy, W. Rod, Yuen, Darren A., Perl, Jeffrey, Chan, Christopher T., Leis, Jerome A., Oliver, Matthew J., Colwill, Karen, Gingras, Anne-Claude, Hladunewich, Michelle A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533557/
https://www.ncbi.nlm.nih.gov/pubmed/37758707
http://dx.doi.org/10.1038/s41467-023-41678-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533557/
https://www.ncbi.nlm.nih.gov/pubmed/37758707
http://dx.doi.org/10.1038/s41467-023-41678-9

Ejemplares similares